Last updated on February 2018

Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer


Brief description of study

The purpose of this study is to treat advanced or recurrent endometrial cancer, paclitaxel-containing regimen is the preferred chemotherapeutic regimen which is selected by most physicians. Docetaxel may have similar efficacy and more favorable treatment related toxicity profile as tested in epithelial ovarian cancer trials. Therefore, the investigators aimed to evaluate the efficacy and safety of docetaxel plus cisplatin in patients with advanced or recurrent endometrial cancer.

Clinical Study Identifier: NCT01461759

Find a site near you

Start Over

Asan Medical Center

Seoul, Korea, Republic of
  Connect »